Search
for
Sort by
Research 151–180 of 326
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- SNP variation in male pattern hair loss in Russians with different dihydrotestosterone levels
- Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- The Effect of Finasteride on Serum Cortisol and testosterone Levels in Rats
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Deciphering of Anti-Alopecia Activity of Polyphenol from Beta vulgaris Root against 5α-reductase: Molecular Insight
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Molecular Docking Studies and ADME-Tox Prediction of Phytocompounds from Punica granatum Peel as a Potential Anti-Alopecia Treatment
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Cloning, computational analysis and expression profiling of steroid 5 alpha-reductase 1 (SRD5A1) gene during reproductive phases and ovatide stimulation in endangered catfish, Clarias magur
- A potential review of its traditional uses, Phytochemistry, pharmacology, and toxicity of Plumbago zeylanica
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Correlation between sebum level and severity of male androgenetic alopecia
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- Phytochemicals as emerging therapeutic agents for alopecia treatment